Modeling Multicancer Screening

Cancer Epidemiol Biomarkers Prev. 2022 Jan;31(1):3-4. doi: 10.1158/1055-9965.EPI-21-1049.


Jiao and colleagues have developed an estimation framework for measuring the benefits of a multi-cancer screening test, notably in terms of cancer detection and deaths prevented. The approach is clear and attractive. Further developments are likely to include more flexible modeling of sensitivities and specificities.See related article by Jiao et al., p. 38.

Publication types

  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Early Detection of Cancer
  • Humans
  • Mass Screening*
  • Neoplasms* / diagnosis
  • Research
  • Sensitivity and Specificity